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Abstract
Background: Idiopathic intracranial hypertension (IIH), also known as pseudotumour cerebri syndrome (PTCS),
is characterized by the presence of signs and symptoms of raised intracranial pressure without evidence of any
intracranial structural cause and with normal cerebrospinal fluid microscopy and biochemistry.
Obesity, various systemic diseases and endocrine conditions, and a number of medications are known to be risk
factors for PTCS. The medications commonly associated with PTCS are amiodarone, antibiotics, corticosteroids,
cyclosporine, growth hormone, oral contraceptives, vitamin A analogues, lithium, phenytoin, NSAIDs, leuprolide
acetate, and some neuroleptic drugs. In relation to antibiotics, quinolones may cause intracranial hypertension,
and most reported cases of quinolone-induced intracranial hypertension were associated with nalidixic acid,
ciprofloxacin, ofloxacin, or pefloxacin. Literature reports of levofloxacin-induced PTCS are rare. Some authors
recently hypothesized that Mycoplasma pneumoniae may trigger PTCS.
Case presentation: We report on a 14-year-old overweight White Italian boy who suffered headache, diplopia,
and severe bilateral papilloedema after a Mycoplasma pneumoniae infection, exacerbated on levofloxacin intake.
A spontaneous improvement in headache and a reduction in diplopia was seen during hospitalisation. Oral
acetazolamide therapy led to the regression of papilloedema in about five months. No permanent eye damage has
been observed in our patient to date.
Conclusions: PTCS pathophysiology may be multifactorial and its specific features and severity may be a consequence
of both constitutional and acquired factors interacting synergistically. It may be useful for paediatricians to know that
some antibiotics may have the potential to precipitate PTCS in patients who already have an increased CSF pressure due
to a transitory imbalanced CSF circulation caused by infections such as Mycoplasma pneumoniae, with headache being
the first and most sensitive, but also the least specific, symptom.
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Background
Idiopathic intracranial hypertension (IIH), also known as
pseudotumour cerebri syndrome (PTCS), is defined as
raised intracranial pressure in the absence of underlying
causes such as intracranial mass lesions, cerebral
malformations, CNS infections, cerebral venous sinus
thrombosis, or hydrocephalus [1, 2].
The incidence of PTCS in children has been estimated
as 0.5–0.9 per 100,000 children per year [1, 3], although
this estimate is based on small or retrospective studies.
Recently, Matthews et al. published a national prospective
population-based cohort study that is a prospective survey
of all cases of paediatric PTCS in the United Kingdom
and establishes, for the first time, reliable estimates of
age-specific, sex-specific and weight-specific annual
incidence rates [4].
The classic symptoms of PTCS are headache, nausea,
tinnitus, blurring of vision and diplopia. In 1937 Dandy
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defined the diagnostic criteria for PTCS [5], and in
2013 Friedman et al. published revised criteria which
categorise PTCS as “definitive”, “probable”, or “suggestive
of PTCS” [6].
The severity of papilloedema may be variable and the
eyes may be asymmetrically involved. Currently, there is
no diagnostic-therapeutic consensus algorithm, since
there are no randomised studies that allow evidence-based
treatment. The management of PTCS remains controver-
sial. The current trend is close clinical monitoring of signs
and symptoms. The therapeutic approach is based on
clinical severity, with particular attention to the degree of
eye involvement [1–3, 7].
The prognosis of PTCS is generally good. With
early diagnosis and treatment, most children have
complete resolution of symptoms. Nevertheless, com-
plications of persistent papilloedema may lead to loss
of visual acuity or even blindness. Ophthalmological as-
sessment and monitoring is therefore strongly recom-
mended by all authors.
The exact pathogenesis of PTCS is unknown and
many associated aetiologies are reported in literature.
Mosquera Gorostidi et al. analysed a total of 12 children
with PTCS and described a possible association with
Mycoplasma pneumoniae [3]. These authors hypothe-
sized that M. pneumoniae may trigger intracranial
hypertension and cause recurrences at later stages.
An iatrogenic hypothesis for PTCS has also been
proposed in the literature and several medications have
been associated with PTCS. The oldest known associ-
ation is with vitamin A and retinoids. Other described
associations are with lithium, steroids, reproductive
hormones (progestins, oestrogens, testosterone, contra-
ception or hormone supplementation therapy), thyroid
replacement therapy, recombinant human growth
hormone, non-steroidal anti-inflammatory drugs and
Nonan and Neem extract, used as a supplement for
infants in southern India [8]. Antibiotics (tetracyclines
(tetracycline, minocycline and doxycycline), sulfameth-
oxazole, gentamicin, cephalexin and quinolones) are also
reported as a possible cause of PTCS. Most reported
cases of quinolone-induced intracranial hypertension
were associated with nalidixic acid [9–12], ciprofloxacin
[13], ofloxacin [14], or pefloxacin [15]. Literature reports
of levofloxacin-induced PTCS intracranial hypertension
are rare [16, 17].
Case presentation
A 14-year-old White Italian boy came to our Emergency
Unit with a headache that had worsened over 20 days to-
gether with blurred vision and diplopia over the previous
10 days. His past history was negative for significant
morbidities. He reported a recent episode of fever
associated with cough, which coincided with the onset
of headache. For this respiratory infection he had started
taking levofloxacin 500mg once a day one week before
coming to our attention but had stopped taking it after
three days due to worsening headache. This headache
was initially associated with daytime somnolence,
myalgia and arthralgia. The somnolence and arthralgia
underwent rapid and spontaneous regression, with
subsequent appearance of blurred vision.
The physical examination revealed an alert adolescent
with weight of 66 kg (75th -90th percentile) [18], height
of 169 cm (50th–75th percentile) [19] and body mass
(BMI) of 23.1 kg/m2 (85th–95th percentile) [19]. The
general examination was normal. The neurological
examination was normal except for a right eye abduction
deficit. Eye examination showed a normal visual acuity
(10/10) in both eyes with normal colour vision and
pupillary light responses, but a fundus examination
revealed severe bilateral papilloedema with elevated disc,
hyperaemia, blurred margins and vessel tortuosity in
both eyes (Fig. 1a-b). Lancaster red-green test confirmed
a right abducens nerve palsy, and campimetry showed a
restricted visual field with external right muscle
deficiency on the right side. Cranial neuroimaging (CT
and MRI) showed a normal brain parenchyma with no
evidence of hydrocephalus, mass, structural lesion, or
abnormal meningeal enhancement. MRI neuroimaging
showed oedema of both optic nerves with a tapered
appearance of the right optic nerve. Venography was not
performed, but an angio-MRI of the cerebral circulation
was normal. Visual evoked cortical potentials were
normal. A 24-h Ambulatory Blood Pressure Monitoring
was negative.
Blood tests showed high M. pneumoniae IgM (15.00
AU/ml, normal range 0–9) and normal M. pneumoniae
IgG levels (3.89 AU/ml, normal range 0–9) suggesting a
recent infection, with normal white blood cell indices
and negative C-reactive protein. Clarithromycin was
then prescribed for 14 days without any adverse effects.
Serological screening for Coxsackie, Parvovirus, ECHO
virus, Adenovirus, Cytomegalovirus (CMV), Epstein-Barr
Virus (EBV), Herpes Simplex Virus 1 (HSV1), and Herpes
Simplex Virus 2 (HSV2) excluded recent infections.
Thyroid function was normal. Antinuclear antibodies
(ANA), anti-double stranded DNA (dsDNA), ENA screen-
ing and rheumatoid factor were negative.
During hospitalisation we observed a complete and
spontaneous regression of headache and an initial
spontaneous reduction in diplopia within a few days.
Oral prednisone 50mg/day (0.75 mg/kg/day) was admin-
istered for a week and ocular fundus was monitored.
Since severe bilateral papilloedema persisted one week
after the first assessment, lumbar puncture was
performed with the patient sedated and relaxed in lateral
recumbent position. Opening cerebrospinal fluid (CSF)
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pressure measured with a standard manometer was
20 cm H2O and closing pressure was 19 cm H2O. These
CSF pressure values have traditionally been considered
borderline, but are within normal range according to a
recent study in children [20].
CSF biochemical tests and cultures were negative.
HSV1, HSV2, VZV, HHV6, CMV, Neisseria, Haemophi-
lus, Streptococcus pneumoniae, Streptococcus B group,
Escherichia coli, Listeria and Cryptococcus neoformans,
Parvovirus, Adenovirus, EBV DNA and Enterovirus and
Parechovirus RNA PCR were negative. CSF oligoclonal
bands were absent on CSF and blood tests.
Oral acetazolamide (1 g divided twice daily) was
introduced to accelerate recovery. A gradual further
improvement in diplopia was seen during hospitalisation
(Fig. 2a-b). Ophthalmological, neurological and neurosur-
gical follow up was continued after discharge. The patient
gradually improved, with complete resolution of the right
abducens nerve palsy in one month and resolution of
papilloedema in three months (Figs. 3 and 4). For this
reason, acetazolamide was gradually reduced and stopped
on resolution of the papilloedema (see Additional file 1).
Discussion and conclusions
This case involved a Mycoplasma pneumoniae infection,
probably occurring before the onset of headache and
disturbed vision. Headache, diplopia and blurred vision
were preceded by respiratory symptoms (cough) and
Fig. 1 a-b IR fundus photography. Elevated disc, blurred margins and vessel tortuosity was found at the first ophthalmological visit in both eyes
(A-right eye, B-left eye)
Fig. 2 a-b IR fundus photography. Reduction in the papilloedema was found after one month of acetazolamide: the margins of the disc appear
sharper but the vessel tortuosity persists (A-right eye, B-left eye)
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systemic symptoms (such as fever, myalgia and
arthralgia), which may be related to M. pneumoniae
infection. As previously described [3], our case sug-
gests that M. pneumoniae may trigger PTCS. Further-
more, in our case the already present headache
dramatically worsened after administration of levo-
floxacin. In fact, the patient decided to stop taking
levofloxacin after just three days.
Quinolone-induced intracranial hypertension is well
described in the literature. The onset of pseudotu-
mour cerebri with quinolones is variable, and can
occur after a few days or several weeks of treatment.
In this case, the clinical course suggests that M.
pneumoniae infection and levofloxacin therapy have a
synergic role in precipitating the most severe symptoms of
raised intracranial pressure.
The delay of lumbar puncture was due to the fact that
during the first days of hospitalization the symptoms
(headache and diplopia) were dramatically and spontan-
eously reduced. For the same reason, a short therapy
with oral prednisone was attempted with the aim of
promoting the reduction of the symptoms which had
already spontaneously started.
A 24-h Ambulatory Blood Pressure Monitoring was
performed because a positive family history for essential
hypertension at a young age was reported.
CSF oligoclonal bands were absent on CSF and blood
tests. It supported the absence of a neurological inflam-
matory disease.
Although lumbar puncture was performed later, when
the symptoms had already improved, we hypothesize
that the CSF pressure must have been higher when the
Fig. 3 OCT performed at the first visit. An abnormal increase in RNFL thickness was observed
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symptoms peaked and the papilloedema probably
developed.
A CSF opening pressure (OP) of ≥28 cm H2O [21]
is considered a diagnostic criterion for PTCS in chil-
dren. However, it has been proposed that a diagnosis
of “probable” PTCS can be made with an OP < 28 cm
H2O, if the other diagnostic criteria are met [22]; OP
values must always be interpreted within the clinical
context as a whole. In our patient OP was 20 cm
H2O, but the presence of 1) clinical signs and symp-
toms of raised intracranial pressure (headache,
diplopia, papilloedema and abducent nerve palsy) without
additional abnormal neurological signs 2) normal mag-
netic resonance imaging and 3) unremarkable examin-
ation of CSF constituents are supportive for a diagnosis of
“probable” PTCS, according to the definition of probable
PTCS given by Tibussek et al. [22].
Treatment principles for “probable” PTCS should be
similar to those used for demonstrated PTCS [22].
Finally, our case suggests that PTCS pathophysiology
may be multifactorial and its specific features and
severity may be a consequence of different factors
interacting synergistically. This observation needs to be
verified in larger studies, but it may be useful for paedia-
tricians to know that some antibiotics may have the
potential to precipitate PTCS in patients who already
have an increased CSF pressure due to a transient imbal-
anced CSF circulation caused by infections such as
M. pneumoniae, with headache being the first and most
sensitive, but also least specific, symptom.
This case also confirmed the importance of a multi-
disciplinary team including paediatricians, paediatric
neurologists, ophthalmologists and neurosurgeons to
ensure the good management of PTCS and its complications.
Fig. 4 OCT performed after three months of acetazolamide. A dramatic reduction in average RNFL thickness was documented
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Although the prognosis is good in most cases, serial
ophthalmological evaluation is required in order to
monitor the evolution of papilloedema and preserve
visual function.
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